Free Trial

Best Penny Stocks Under 25 Cents Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. These penny stocks all have a super-low share price of $0.25 or less and are sorted by average trading volume in dollars. These companies are considered the most actively-traded stocks priced under $0.25.

Nikola stock logo

1. Nikola NASDAQ:NKLA

$0.18 -0.07 (-28.74%)
Closing price 02/25/2025
Extended Trading
$0.18 0.00 (0.00%)
As of 02/25/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions in the United States and internationally. More about Nikola

Market Capitalization
$11.14 million
P/E Ratio
-0.01
Consensus Rating
Hold
Consensus Price Target
$12.00 (+6,457.4% Upside)
Volume
36.66 million shares
Average Volume
8.39 million shares
GlycoMimetics stock logo

2. GlycoMimetics NASDAQ:GLYC

$0.20 +0.01 (+3.75%)
Closing price 04/11/2025 04:00 PM Eastern
Extended Trading
$0.20 0.00 (-1.93%)
As of 04/11/2025 07:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GlycoMimetics, Inc, a biotechnology company, focuses on the discovery and development of therapies for cancers and inflammatory diseases in the United States. More about GlycoMimetics

Market Capitalization
$13.03 million
Consensus Rating
Hold
Volume
124,317 shares
Average Volume
6.74 million shares
Today's Range
$0.19
$0.21
50-Day Range
$0.18
$0.36
WW International stock logo

3. WW International NASDAQ:WW

$0.19 +0.00 (+0.48%)
Closing price 04/11/2025 04:00 PM Eastern
Extended Trading
$0.18 -0.01 (-5.26%)
As of 04/11/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

WW International, Inc provides weight management products and services worldwide. It offers a range of nutritional, activity, behavioral, and lifestyle tools and approaches products and services. More about WW International

Market Capitalization
$15.22 million
P/E Ratio
-0.03
Consensus Rating
Hold
Consensus Price Target
$3.00 (+1,478.9% Upside)
Volume
5.64 million shares
Average Volume
4.62 million shares
X4 Pharmaceuticals stock logo

4. X4 Pharmaceuticals NASDAQ:XFOR

$0.21 0.00 (-0.76%)
Closing price 04/11/2025 04:00 PM Eastern
Extended Trading
$0.21 +0.00 (+1.90%)
As of 04/11/2025 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

X4 Pharmaceuticals, Inc, a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. More about X4 Pharmaceuticals

Market Capitalization
$36.47 million
P/E Ratio
-2.33
Consensus Rating
Buy
Consensus Price Target
$2.83 (+1,249.2% Upside)
Volume
1.92 million shares
Average Volume
2.81 million shares
Adaptimmune Therapeutics stock logo

5. Adaptimmune Therapeutics NASDAQ:ADAP

$0.22 +0.01 (+3.40%)
Closing price 04/11/2025 04:00 PM Eastern
Extended Trading
$0.22 +0.00 (+1.21%)
As of 04/11/2025 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. More about Adaptimmune Therapeutics

Market Capitalization
$57.18 million
P/E Ratio
-1.01
Consensus Rating
Moderate Buy
Consensus Price Target
$1.83 (+723.2% Upside)
Volume
1.54 million shares
Average Volume
1.78 million shares
Fusion Fuel Green stock logo

6. Fusion Fuel Green NASDAQ:HTOO

$0.24 +0.02 (+8.49%)
Closing price 04/11/2025 04:00 PM Eastern
Extended Trading
$0.24 +0.00 (+0.41%)
As of 04/11/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Fusion Fuel Green PLC, together with its subsidiaries, manufactures and sells miniaturized PEM electrolyzers to produce green hydrogen in Portugal, Spain, and rest of southern Europe. More about Fusion Fuel Green

Market Capitalization
$5.72 million
Consensus Rating
Buy
Consensus Price Target
$3.50 (+1,334.4% Upside)
Volume
138,405 shares
Average Volume
1.52 million shares
Today's Range
$0.21
$0.25
Remove Ads
Omega Therapeutics stock logo

7. Omega Therapeutics NASDAQ:OMGA

$0.12 -0.03 (-21.83%)
Closing price 02/24/2025
Extended Trading
$0.12 0.00 (0.00%)
As of 02/24/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Omega Therapeutics, Inc operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. More about Omega Therapeutics

Market Capitalization
$6.92 million
P/E Ratio
-0.09
Consensus Rating
Moderate Buy
Consensus Price Target
$9.20 (+7,260.0% Upside)
Volume
4.81 million shares
Average Volume
2.74 million shares
Cyclacel Pharmaceuticals stock logo

8. Cyclacel Pharmaceuticals NASDAQ:CYCC

$0.24 +0.02 (+7.66%)
Closing price 04/11/2025 04:00 PM Eastern
Extended Trading
$0.24 +0.01 (+2.09%)
As of 04/11/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cyclacel Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases in the United States, the United Kingdom, and internationally. More about Cyclacel Pharmaceuticals

Market Capitalization
$1.50 million
P/E Ratio
-0.03
Consensus Rating
Moderate Buy
Consensus Price Target
$11.00 (+4,502.5% Upside)
Volume
169,945 shares
Average Volume
1.21 million shares
Scilex stock logo

9. Scilex NASDAQ:SCLX

$0.20 -0.05 (-21.53%)
Closing price 04/11/2025 04:00 PM Eastern
Extended Trading
$0.20 +0.01 (+4.54%)
As of 04/11/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. More about Scilex

Market Capitalization
$47.71 million
P/E Ratio
-0.24
Consensus Rating
Moderate Buy
Consensus Price Target
$13.00 (+6,529.3% Upside)
Volume
5.09 million shares
Average Volume
1.45 million shares
IN8bio stock logo

10. IN8bio NASDAQ:INAB

$0.15 +0.01 (+3.40%)
Closing price 04/11/2025 04:00 PM Eastern
Extended Trading
$0.15 0.00 (-0.72%)
As of 04/11/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IN8bio, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. More about IN8bio

Market Capitalization
$12.36 million
P/E Ratio
-0.20
Consensus Rating
Buy
Consensus Price Target
$6.00 (+3,844.8% Upside)
Volume
594,836 shares
Average Volume
1.83 million shares
Processa Pharmaceuticals stock logo

11. Processa Pharmaceuticals NASDAQ:PCSA

$0.25 -0.01 (-4.31%)
Closing price 04/11/2025 04:00 PM Eastern
Extended Trading
$0.22 -0.03 (-12.38%)
As of 04/11/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Processa Pharmaceuticals, Inc, a clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment. More about Processa Pharmaceuticals

Market Capitalization
$1.31 million
P/E Ratio
-0.07
Consensus Rating
Buy
Consensus Price Target
$6.00 (+2,311.6% Upside)
Volume
617,483 shares
Average Volume
991,781 shares
Remove Ads
Bio-Path stock logo

12. Bio-Path NASDAQ:BPTH

$0.14 -0.01 (-9.10%)
As of 04/11/2025 03:50 PM Eastern

Bio-Path Holdings, Inc operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. More about Bio-Path

Market Capitalization
$1.19 million
Consensus Rating
Buy
Consensus Price Target
$20.00 (+13,905.6% Upside)
Volume
78,791 shares
Average Volume
1.60 million shares
Today's Range
$0.14
$0.17
Beyond Air stock logo

13. Beyond Air NASDAQ:XAIR

$0.24 +0.01 (+2.70%)
Closing price 04/11/2025 04:00 PM Eastern
Extended Trading
$0.24 0.00 (-0.08%)
As of 04/11/2025 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. More about Beyond Air

Market Capitalization
$16.25 million
P/E Ratio
-0.22
Consensus Rating
Buy
Consensus Price Target
$3.67 (+1,452.4% Upside)
Volume
406,819 shares
Average Volume
947,822 shares
Lyra Therapeutics stock logo

14. Lyra Therapeutics NASDAQ:LYRA

$0.10 +0.02 (+20.38%)
Closing price 04/11/2025 04:00 PM Eastern
Extended Trading
$0.10 +0.00 (+0.78%)
As of 04/11/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lyra Therapeutics, Inc, a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. More about Lyra Therapeutics

Market Capitalization
$6.73 million
P/E Ratio
-0.07
Consensus Rating
Hold
Consensus Price Target
$1.25 (+1,123.1% Upside)
Volume
1.34 million shares
Average Volume
1.96 million shares
Ryde Group stock logo

15. Ryde Group NYSEAMERICAN:RYDE

$0.23 0.00 (-0.61%)
Closing price 04/11/2025 04:10 PM Eastern
Extended Trading
$0.23 0.00 (-0.22%)
As of 04/11/2025 07:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ryde Group Ltd engages in mobility and quick commerce businesses in Singapore. The Mobility segment provides on-demand and scheduled carpooling and ride-hailing services. More about Ryde Group

Market Capitalization
$4.33 million
Consensus Rating
Buy
Consensus Price Target
$9.00 (+3,873.5% Upside)
Volume
51,732 shares
Average Volume
855,391 shares
Today's Range
$0.22
$0.24
Syros Pharmaceuticals stock logo

16. Syros Pharmaceuticals NASDAQ:SYRS

$0.02 0.00 (-4.00%)
As of 04/11/2025 03:55 PM Eastern

Syros Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. More about Syros Pharmaceuticals

Market Capitalization
$1.65 million
P/E Ratio
-0.01
Consensus Rating
Hold
Consensus Price Target
$3.33 (+13,788.9% Upside)
Volume
202,930 shares
Average Volume
8.02 million shares
Remove Ads
Gogoro stock logo

17. Gogoro NASDAQ:GGR

$0.23 +0.02 (+10.48%)
Closing price 04/11/2025 04:00 PM Eastern
Extended Trading
$0.23 +0.00 (+0.43%)
As of 04/11/2025 06:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Gogoro Inc provides battery swapping services in Taiwan, India, and internationally. It also develops Swap and Go battery system that delivers full power to electric-powered two-wheelers. More about Gogoro

Market Capitalization
$68.52 million
P/E Ratio
-0.52
Consensus Rating
Hold
Consensus Price Target
$0.50 (+115.5% Upside)
Volume
1.51 million shares
Average Volume
754,265 shares
Gryphon Digital Mining stock logo

18. Gryphon Digital Mining NASDAQ:GRYP

$0.16 +0.01 (+4.67%)
Closing price 04/11/2025 04:00 PM Eastern
Extended Trading
$0.16 0.00 (-0.64%)
As of 04/11/2025 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Gryphon Digital Mining, Inc operates as a bitcoin mining company in the United States. It operates mining computers and ESG-led mining. More about Gryphon Digital Mining

Market Capitalization
$8.13 million
P/E Ratio
-0.29
Consensus Rating
Hold
Volume
409,091 shares
Average Volume
1.06 million shares
Today's Range
$0.14
$0.16
P3 Health Partners stock logo

19. P3 Health Partners NASDAQ:PIII

$0.15 -0.01 (-7.62%)
Closing price 04/11/2025 04:00 PM Eastern
Extended Trading
$0.15 0.00 (-0.40%)
As of 04/11/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. More about P3 Health Partners

Market Capitalization
$54.44 million
P/E Ratio
-0.18
Consensus Rating
Hold
Consensus Price Target
$0.25 (+64.9% Upside)
Volume
393,598 shares
Average Volume
986,319 shares
Aspira Women's Health stock logo

20. Aspira Women's Health NASDAQ:AWH

$0.10 +0.00 (+2.53%)
Closing price 04/11/2025 04:00 PM Eastern
Extended Trading
$0.09 -0.01 (-5.25%)
As of 04/11/2025 07:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aspira Women's Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. More about Aspira Women's Health

Market Capitalization
$2.89 million
P/E Ratio
-0.08
Consensus Rating
Buy
Consensus Price Target
$5.50 (+5,564.3% Upside)
Volume
754,881 shares
Average Volume
1.19 million shares
Wag! Group stock logo

21. Wag! Group NASDAQ:PET

$0.13 +0.00 (+0.39%)
Closing price 04/11/2025 04:00 PM Eastern
Extended Trading
$0.13 +0.00 (+0.94%)
As of 04/11/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Wag! Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent pet caregivers to connect with pet parents. More about Wag! Group

Market Capitalization
$6.48 million
P/E Ratio
-0.33
Consensus Rating
Moderate Buy
Consensus Price Target
$4.90 (+3,734.1% Upside)
Volume
175,185 shares
Average Volume
893,802 shares
Cutera stock logo

22. Cutera NASDAQ:CUTR

$0.04 -0.07 (-63.86%)
Closing price 03/12/2025
Extended Trading
$0.04 0.00 (0.00%)
As of 03/12/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. More about Cutera

Market Capitalization
$787 thousand
P/E Ratio
-0.01
Consensus Rating
Moderate Buy
Consensus Price Target
$3.00 (+7,592.3% Upside)
Volume
27.70 million shares
Average Volume
2.27 million shares
Carisma Therapeutics stock logo

23. Carisma Therapeutics NASDAQ:CARM

$0.21 +0.01 (+4.02%)
Closing price 04/11/2025 04:00 PM Eastern
Extended Trading
$0.20 0.00 (-1.93%)
As of 04/11/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Carisma Therapeutics, Inc, a clinical-stage cell therapy company, focuses on discovering and developing immunotherapies to treat cancer and other serious diseases in the United States. More about Carisma Therapeutics

Market Capitalization
$8.65 million
P/E Ratio
-0.13
Consensus Rating
Hold
Consensus Price Target
$1.93 (+830.0% Upside)
Volume
95,079 shares
Average Volume
380,457 shares
Palatin Technologies stock logo

24. Palatin Technologies NYSEAMERICAN:PTN

$0.16 -0.26 (-60.93%)
Closing price 04/11/2025 04:10 PM Eastern
Extended Trading
$0.17 +0.01 (+5.45%)
As of 04/11/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Palatin Technologies, Inc, a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. More about Palatin Technologies

Market Capitalization
$4.29 million
P/E Ratio
-0.11
Consensus Rating
Buy
Consensus Price Target
$7.00 (+4,142.4% Upside)
Volume
6.34 million shares
Average Volume
467,794 shares
Leafly stock logo

25. Leafly NASDAQ:LFLY

$0.20 +0.03 (+17.58%)
As of 04/11/2025 03:54 PM Eastern

Leafly Holdings, Inc owns and operates a platform to provide consumers with cannabis information and connects consumers to cannabis brands and licensed retailers. More about Leafly

Market Capitalization
$615 thousand
P/E Ratio
-0.09
Consensus Rating
Buy
Consensus Price Target
$9.18 (+4,490.0% Upside)
Volume
1,201 shares
Average Volume
367,727 shares